日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout

肉瘤细胞疗法的未来方向和优先事项:肉瘤科学战略进展细胞疗法分会报告

Oliva-Ramirez, Jacqueline; Milewski, David; Banks, Lauren; Bailey, Kelly M; Moding, Everett J; Lake, Jessica; Chen, Alice; Daley, Jessica D; Resch, Erin E; Kaplan, Rosandra N; Ladle, Brian H; Zhang, Lindy; Chou, Margaret M; Nguyen, Rosa; Dagalakis, Urania; Al Akoum, Nourhane; Sorensen, Poul H; Fletcher, Jonathan A; DeMatteo, Ronald; Llosa, Nicolas J; Pollack, Seth M

Ferroptosis as a therapeutic vulnerability in MDM2 inhibition in dedifferentiated liposarcoma.

铁死亡是去分化脂肪肉瘤中 MDM2 抑制治疗的弱点

Yen Chueh-Chuan, Chen Paul Chih-Hsueh, Chen San-Chi, Wu Wen-Chi, Yen Chiao-Han, Lin Yung-Chan, Wu Po-Kuei, Chen Chao-Ming, Wang Jir-You, Chao Ta-Chung, Yang Muh-Hwa, Fletcher Jonathan A

KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape

胃肠道间质瘤中KIT ATP结合口袋/激活环突变:激酶抑制剂逃逸的新机制

Mühlenberg, Thomas; Falkenhorst, Johanna; Schulz, Tom; Fletcher, Benjamin S; Teuber, Alina; Krzeciesa, Dawid; Klooster, Isabella; Lundberg, Meijun; Wilson, Lydia; Lategahn, Jonas; von Mehren, Margaret; Grunewald, Susanne; Tüns, Alicia Isabell; Wardelmann, Eva; Sicklick, Jason K; Brahmi, Mehdi; Serrano, César; Schildhaus, Hans-Ulrich; Sievers, Sonja; Treckmann, Jürgen; Heinrich, Michael C; Raut, Chandrajit P; Ou, Wen-Bin; Marino-Enriquez, Adrian; George, Suzanne; Rauh, Daniel; Fletcher, Jonathan A; Bauer, Sebastian

Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.

对 NHEJ 的过度依赖使得 DNA-PK 抑制剂与低剂量阿霉素在平滑肌肉瘤中产生协同作用

Marino-Enriquez Adrian, Novotny Jan Philipp, Gulhan Doga C, Klooster Isabella, Tran Antuan V, Kasbo Macy, Lundberg Meijun Z, Ou Wen-Bin, Tao Derrick L, Pilco-Janeta Daniel F, Mao Victor Y, Zenke Frank T, Leeper Brittaney A, Gokhale Prafulla C, Cowley Glenn S, Baker Laurence H, Ballman Karla V, Root David E, Albers Joachim, Park Peter J, George Suzanne, Fletcher Jonathan A

Targeting DNA-PK

靶向DNA-PK

Novotny, Jan Philipp; Mariño-Enríquez, Adrian; Fletcher, Jonathan A

PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.

癌症中的 PRC2 失活突变通过增强病毒模拟来增强对 DNMT1 靶向治疗的细胞毒性反应

Patel Amish J, Warda Sarah, Maag Jesper L V, Misra Rohan, Miranda-Román Miguel A, Pachai Mohini R, Lee Cindy J, Li Dan, Wang Naitao, Bayshtok Gabriella, Fishinevich Eve, Meng Yinuo, Wong Elissa W P, Yan Juan, Giff Emily, Pappalardi Melissa B, McCabe Michael T, Fletcher Jonathan A, Rudin Charles M, Chandarlapaty Sarat, Scandura Joseph M, Koche Richard P, Glass Jacob L, Antonescu Cristina R, Zheng Deyou, Chen Yu, Chi Ping

Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas

489例平滑肌肉瘤中高复发性肿瘤抑制基因改变之间的关系

Schaefer, Inga-Marie; Lundberg, Meijun Z; Demicco, Elizabeth G; Przybyl, Joanna; Matusiak, Magdalena; Chibon, Frédéric; Ingram, Davis R; Hornick, Jason L; Wang, Wei-Lien; Bauer, Sebastian; Baker, Laurence H; Lazar, Alexander J; van de Rijn, Matt; Mariño-Enríquez, Adrian; Fletcher, Jonathan A

Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors

下一代测序技术在胃肠道间质瘤血浆游离DNA研究中的临床价值

Serrano, César; Vivancos, Ana; López-Pousa, Antonio; Matito, Judit; Mancuso, Francesco M; Valverde, Claudia; Quiroga, Sergi; Landolfi, Stefania; Castro, Sandra; Dopazo, Cristina; Sebio, Ana; Virgili, Anna C; Menso, María M; Martín-Broto, Javier; Sansó, Miriam; García-Valverde, Alfonso; Rosell, Jordi; Fletcher, Jonathan A; George, Suzanne; Carles, Joan; Arribas, Joaquín

Mutational inactivation of mTORC1 repressor gene DEPDC5 in human gastrointestinal stromal tumors

人类胃肠道间质瘤中mTORC1抑制基因DEPDC5的突变失活

Pang, Yuzhi; Xie, Feifei; Cao, Hui; Wang, Chunmeng; Zhu, Meijun; Liu, Xiaoxiao; Lu, Xiaojing; Huang, Tao; Shen, Yanying; Li, Ke; Jia, Xiaona; Li, Zhang; Zheng, Xufen; Wang, Simin; He, Yi; Wang, Linhui; Fletcher, Jonathan A; Wang, Yuexiang

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

更正:酪氨酸激酶抑制剂对伊马替尼耐药性胃肠道间质瘤中继发性kit突变的互补活性

Serrano, César; Mariño-Enríquez, Adrián; Tao, Derrick L; Ketzer, Julia; Eilers, Grant; Zhu, Meijun; Yu, Channing; Mannan, Aristotle M; Rubin, Brian P; Demetri, George D; Raut, Chandrajit P; Presnell, Ajia; McKinley, Arin; Heinrich, Michael C; Czaplinski, Jeffrey T; Sicinska, Ewa; Bauer, Sebastian; George, Suzanne; Fletcher, Jonathan A